Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07556679 · ClinicalTrials.gov registry record · NA

PLAY2CONTROL Study

A NA study, sponsored by University of Miami.

Not yet
Registry status
NA
Development phase
30
Enrollment target

NCT07556679: Clinical Trial NA study, sponsored by University of Miami.

NCT07556679 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07556679, a NA study, has not yet begun recruiting, sponsored by University of Miami.

NOT YET RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to assess the impact of active video gaming participation in otherwise sedentary patients with obesity and Type 2 diabetes mellitus. The study will assess changes in sedentary time, activity level and changes in weight and Hemoglobin A1c, as well as other complications related to obesity that is monitored in clinic.

Primary Outcome

Percent change in body weight (percentage points) from baseline, measured using clinic calibrated scales during routine visits

Interventions

  • BEHAVIORAL Nex Playground Activity Program

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-08
Est. Completion 2027-08
Phase NA
University of Miami

721 total trials

What is known before NCT07556679 opens enrollment

NCT07556679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Nex Playground Activity Program is the first listed.

NCT07556679 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07556679 about?

NCT07556679 is a clinical study titled "PLAY2CONTROL Study". The purpose of this study is to assess the impact of active video gaming participation in otherwise sedentary patients with obesity and Type 2 diabetes mellitus. The study will assess changes in sedentary time, activity level and changes in weight and Hemoglobin A1c, as well as other complications r...

What is the current status of trial NCT07556679?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-08. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07556679?

The interventions under investigation include: Nex Playground Activity Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07556679?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07556679's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07556679, the US trial registry maintained by the National Library of Medicine. NCT07556679 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.